Clinical Trials Logo

Adherence, Medication clinical trials

View clinical trials related to Adherence, Medication.

Filter by:

NCT ID: NCT05332158 Recruiting - Clinical trials for Adherence, Medication

Medicines Gaps Study

MeGa
Start date: May 30, 2022
Phase: N/A
Study type: Interventional

The adherence project aims to understand adherence rates and barriers to Direct oral anticoagulants (DOACs) and statins and improve awareness of healthcare professionals on adherence across Leeds. During the first component of the project, the investigation of rates of non-adherence was classed as service evaluation. The second component of this project, which this IRAS application refers to, will look into patient perspectives and barriers to adherence. Currently, such information is not routinely collected and only requested as part of shorter or longer consultations depending on a pre-defined clinical agenda and with little attention to adherence. Two specific questionnaires have been designed and integrated within the primary care medical records systems. Following invitation for target patients on DOACs and/or statins to respond anonymously, responses to the questionnaire(s) will be stored in their medical records. Data will then be extracted from the two systems [SystmOne and Egton Medical Information Systems (EMIS)] using unique system identifiers, that will be pseudonymised at the time of extraction. All patient pseudonymised information (including medical records system identifiers and responses to the questionnaire) will be extracted by the LTHT Researcher-Pharmacist following access provided by each participating General Practitioner (GP) Practice, based on searches built centrally by the Data Quality Team of the Leeds Clinical Commissioning Group (CCG). Apart from the dissemination of findings based on the questionnaire, a training package for health professionals will be designed and delivered. The aim of the training is to combine and disseminate all findings of the project, raise awareness on real-world non-adherence prevalence and the common barriers to adherence, demonstrate the usefulness of routine adherence estimation and suggest tools to address non-adherence in daily practice. The objectives of this training will also consider the training needs of healthcare professionals locally, as per the healthcare professionals survey that has been designed and circulated.

NCT ID: NCT05312242 Completed - Clinical trials for Adherence, Medication

Introduction of MMS to Antenatal Care in Bamako, Mali

MAMAN
Start date: February 10, 2022
Phase: N/A
Study type: Interventional

The aim of this implementation research is to compare how different implementation strategies influence the acceptability and adherence to antenatal supplement use in pregnancy.

NCT ID: NCT05301855 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Adherence and Beliefs About Medications, and Illness Perception Among Type 2 Diabetic Patients in Assiut Main Hospital

Start date: March 2022
Phase:
Study type: Observational

Diabetes mellitus (DM) is considered one of the oldest fast-growing publichealth problems. It's a chronic metabolic disorder characterized mainly by highlevel of glucose level, associated globally with increased morbidity andmortality particularly in developing countries [1].DM leads to serious problems in heart, blood vessels, kidney and nerves.The World Health Organization (WHO) had anticipated that DM is going tobecome the seventh most significant primary cause of death worldwide by theyear 2030 [2]

NCT ID: NCT05291000 Completed - Hypertension Clinical Trials

The Role of Training and Reminder Wristwatche in Hypertension

RoT-ReWiH
Start date: April 1, 2019
Phase: N/A
Study type: Interventional

This study is a randomized controlled study. The study was completed to with randomized selected 30 training and reminder by watch (experiment), 30 education (experiment) and 30 control group total of 90 hypertensive patients. Patients in the experimental group received training on hypertension and treatment adherence. In addition, the participants in the training and reminder by watch group wore a medication reminder wristwatch. Statistically significant differences were found in the post-test between scale scores of the experimental and control groups (p<.05). It was observed that the initial blood pressure measurements were high in the patients in all three groups, while the highest decrease was found in the training and reminder by wristwatch group at the final measurement (p<.05). Hypertension education program and using a medication reminder wristwatch were found to be effective in increasing treatment adherence.

NCT ID: NCT05286216 Not yet recruiting - Quality of Life Clinical Trials

The Effect of Education on Drug Compliance and Quality of Life in Hepatitis B Patients

Start date: April 15, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to determine the effect of the education given to patients with CHB who use oral antiviral drugs on oral antiviral drug use on drug compliance and quality of life.

NCT ID: NCT05278000 Recruiting - Asthma in Children Clinical Trials

Improving Adherence to Controller Medication in Children With Asthma

PACIFI
Start date: August 25, 2022
Phase:
Study type: Observational

Asthma is a common pediatric condition that can be well controlled with regular use of controller medications, however adherence to these is low, resulting in preventable exacerbations and important short- and long-term morbidity. This project's aim is to understand cognitive factors influencing adherence to medication among children with asthma, examining specifically the influence of scarcity (a mindset experienced by those with less than they need, which is cognitively taxing) and future discounting (the focus on present concerns at the expense of distant ones). Using a single-centre, 12-month, prospective observation cohort study of 300 families of children with asthma, the objectives of this study are to: 1. Identify the relationship between scarcity, future discounting, and adherence to asthma medication. 2. Evaluate whether unmet social needs are associated with scarcity and future discounting. 3. Determine whether scarcity and future discounting mediate the relationship between unmet social needs and adherence to medication. Primary outcome will be adherence to controller medication, which will be measured for the 12 months of follow-up on a scale of 0 to 100%, by the 'proportion of prescribed days covered (PPDC)', a validated index calculated as the number of days for which the drug was dispensed by a pharmacy, divided by the number of days for which it was prescribed. Other measures include screening families for unmet social needs, psychometric testing to document scarcity and future discounting. This study will increase our understanding of how cognitive factors influence adherence to asthma controller medication, which will be instrumental in developing targeted interventions to improve adherence, especially for families experiencing with unmet social needs.

NCT ID: NCT05233644 Completed - Heart Failure Clinical Trials

Medication Adherence in Heart Failure After Hospitalisation

Start date: October 28, 2021
Phase:
Study type: Observational

To explore medication adherence in patients who were hospitalised due to heart failure.

NCT ID: NCT05207449 Not yet recruiting - Quality of Life Clinical Trials

Health Challenges for Adolescents With Chronic Diseases in Egypt

Start date: March 1, 2022
Phase:
Study type: Observational

The World Health Organization (WHO) defines adolescents as those people between 10 and 19 years of age. Adolescence is a critical developmental stage especially in the context of living with a chronic disease (CD), a chronic disease can be defined as "physiological, behavioral or cognitive disorder that has lasted for one year and produces one or more types of consequences: functional constraints, dependency on compensatory assistance for functioning, or increased need of service compared with age-mates". The burden of chronic conditions in adolescence is increasing as larger numbers of chronically ill children survive beyond the age of 10. Over 85% of children with congenital or chronic conditions now survive into adolescence, and conditions once seen only in young children are now seen beyond childhood and adolescence.

NCT ID: NCT05168449 Completed - Clinical trials for Chronic Kidney Diseases

The Impact of Pharmacist-led Mobile Application on Adherence in Chronic Kidney Disease Patients

Start date: September 17, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to assess the impact of pharmacist led mobile application on adherence and efficacy of medication in chronic kidney disease patients

NCT ID: NCT05140876 Recruiting - HIV-1-infection Clinical Trials

Supporting Treatment Adherence for Resilience and Thriving (START)

START
Start date: June 15, 2022
Phase: N/A
Study type: Interventional

This Phase II randomized controlled trial is testing the efficacy of a cell phone application called START for helping men who use stimulants like methamphetamine to get the most out of their HIV treatment.